Shibei Du
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Shibei Du has a total of 18 co-authors. Here are the top co-authors by number of shared publications:
Anushree Balachandran
Children's Cancer Institute Australia for Medical Research, Lowy Cancer Research Centre, UNSW Sydney, Kensington, NSW, Australia
1 shared publicationBelamy B. Cheung
Department of Pediatric Hematology & Oncology, Xinhua Hospital Affiliated to Shanghai Jiao Tong University, School of Medicine, Shanghai, China; Children's Cancer Institute Australia for Medical Research, Lowy Cancer Research Centre, UNSW Sydney, Kensington, NSW, Australia; School of Women's and Children's Health, UNSW Sydney, Randwick, NSW 2031, Australia
1 shared publication- Chao Zhang
Department of Orthopedics and Precision Research Center for Refractory Diseases, Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine
1 shared publication - Daniel R. Carter
Children’s Cancer Institute Australia for Medical Research, Lowy Cancer Research Centre, UNSW Sydney, Sydney, Australia
1 shared publication Glenn M. Marshall
Children's Cancer Institute Australia for Medical Research, Lowy Cancer Research Centre, UNSW Sydney, Kensington, NSW, Australia; School of Women's and Children's Health, UNSW Sydney, Randwick, NSW 2031, Australia; Kids Cancer Centre, Sydney Children's Hospital, Randwick, NSW 2031, Australia
1 shared publication- Janith A. Seneviratne
Peter MacCallum Cancer Centre, Melbourne, Victoria 3000, Australia
1 shared publication
Latest Publications
- Open Access
- 4 October 2022
- Published by Elsevier in Cell Reports
- Vol. 41 (1) , 111455
Single-cell profiling of peripheral neuroblastic tumors identifies an aggressive transitional state that bridges an adrenergic-mesenchymal trajectory
- 4 October 2022
- Published by Elsevier in Cell Reports
- Vol. 41 (1) , 111455
Open AccessSingle-cell profiling of peripheral neuroblastic tumors identifies an aggressive transitional state that bridges an adrenergic-mesenchymal trajectory